No innovative pharma company selling into the reimbursed market anywhere in the world can hope any more to escape scrutiny of the cost and the value of their medicines.
States and other actors continue to worry away at the established rules of play in various areas.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?